These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26432964)

  • 1. Validation of the lower urinary tract symptom score.
    Blaivas JG; Tsui JF; Mekel G; Benedon MS; Li B; Friedman FM; Weinberger JM; Weedon J; Weiss JP
    Can J Urol; 2015 Oct; 22(5):7952-8. PubMed ID: 26432964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S).
    Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG
    Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of lower urinary tract symptoms in men by international prostate symptom score and core lower urinary tract symptom score.
    Fujimura T; Kume H; Nishimatsu H; Sugihara T; Nomiya A; Tsurumaki Y; Miyazaki H; Suzuki M; Fukuhara H; Enomoto Y; Homma Y
    BJU Int; 2012 May; 109(10):1512-6. PubMed ID: 21883834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires.
    Wróbel A; Skorupska K; Rechberger E; Woźniak A; Miotla P; Kubik-Komar A; Skorupski P; Rechberger T
    Int Urogynecol J; 2019 Dec; 30(12):2135-2139. PubMed ID: 31396639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of voiding dysfunction in Parkinson's disease: Reliability and validity of the Turkish version of the Danish Prostate Symptom Score.
    Akkoç Y; Gök H; Karapolat H; Ersöz M; Sungur U; Köklü K; Alemdaroğlu E; Tunç H; Acarer A; Özer İŞ; Akbostancı C; Arlı B; Yoldaş TK
    Neurourol Urodyn; 2017 Sep; 36(7):1903-1909. PubMed ID: 28139847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translation and linguistic validation of the Persian version of the Bristol Female Lower Urinary Tract Symptoms instrument.
    Pourmomeny AA; Rezaeian ZS; Soltanmohamadi M
    Int Urogynecol J; 2017 Sep; 28(9):1329-1333. PubMed ID: 28160011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the 8-item overactive bladder questionnaire (OAB-v8) using item response theory.
    Peterson AC; Sehgal A; Crump RT; Baverstock R; Sutherland JM; Carlson K
    Neurourol Urodyn; 2018 Mar; 37(3):1095-1100. PubMed ID: 28976596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the overactive bladder symptom score.
    Blaivas JG; Panagopoulos G; Weiss JP; Somaroo C
    J Urol; 2007 Aug; 178(2):543-7; discussion 547. PubMed ID: 17570417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Turkish version of the eight-item actionable bladder symptom screening tool in multiple sclerosis.
    Polat Dunya C; Tulek Z; Vızvız GY; Gündüz T; Panicker JN; Kürtüncü M; Eraksoy M
    Neurourol Urodyn; 2020 Jan; 39(1):243-252. PubMed ID: 31588627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validation of the Dutch OAB-q SF: An overactive bladder symptom bother and health-related quality of life short-form questionnaire.
    Groenendijk IM; Scheepe JR; Noordhoff TC; Blok BFM
    Neurourol Urodyn; 2019 Aug; 38(6):1775-1782. PubMed ID: 31215693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the Patient Perception of Intensity of Urgency Scale in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Mathias SD; Crosby RD; Nazir J; Klaver M; Drogendijk T; Hakimi Z; Odeyemi IA
    Value Health; 2014 Dec; 17(8):823-9. PubMed ID: 25498777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions.
    Van Batavia JP; Combs AJ; Fast AM; Glassberg KI
    J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
    Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
    Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
    Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms.
    Choi EP; Lam CL; Chin WY
    Health Qual Life Outcomes; 2014 Jan; 12():1. PubMed ID: 24382363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study.
    Lee KS; Yoo TK; Liao L; Wang J; Chuang YC; Liu SP; Chu R; Sumarsono B
    BMC Urol; 2017 Nov; 17(1):108. PubMed ID: 29162085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive evaluation of bladder and urethral dysfunction symptoms: development and psychometric validation of the Urinary Symptom Profile (USP) questionnaire.
    Haab F; Richard F; Amarenco G; Coloby P; Arnould B; Benmedjahed K; Guillemin I; Grise P
    Urology; 2008 Apr; 71(4):646-56. PubMed ID: 18313122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptoms.
    Chapple CR; Drake MJ; Van Kerrebroeck P; Cardozo L; Drogendijk T; Klaver M; Van Charldorp K; Hakimi Z; Compion G
    BJU Int; 2014 May; 113(5):696-703. PubMed ID: 24712917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a new treatment outcome score for men with LUTS.
    Weiss JP; Blaivas JG; Tash Anger JA; Di Blasio CJ; Panagopoulos G; Gerboc J
    Neurourol Urodyn; 2004; 23(2):88-93. PubMed ID: 14983416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α-blocker treatment for lower urinary tract symptoms.
    Kaplan SA; Roehrborn CG; Gong J; Sun F; Guan Z
    BJU Int; 2012 Jun; 109(12):1831-40. PubMed ID: 21966995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.